Tech Company Financing Transactions
Amunix Pharmaceuticals Funding Round
Omega Funds, Casdin Capital and Delian Capital participated in a $73 million Series A venture round for Amunix Pharmaceuticals. The funding round was recorded on 3/5/2020.
Transaction Overview
Omega Funds (Lead Investor) (Otello Stampacchia)
Frazier Healthcare Partners (James Brush)
Longitude Capital Management (David Hirsch)
Company Information
San Francisco, CA 94080
USA
Management Team
Browse more venture capital transactions:
Prev: 3/5/2020: OutMatch venture capital transaction
Next: 3/5/2020: BoxLock venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. All VC database entries reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs